Tonix Pharmaceuticals Announces AI Collaboration with X‑Chem to Develop Broad-Spectrum Antivirals
AI (Artificial Intelligence) and ML (Machine Learning) drug discovery collaboration will accelerate the development of small molecules as orally available...
X‑Chem Announces Candidate Milestone
WALTHAM, Mass.; Sept. 17, 2024 (Business Wire) – X-Chem, a global leader in innovative drug discovery services, announces the achievement...
Evotec and X‑Chem Collaborate to Accelerate Early-Stage Drug Discovery
WALTHAM, Mass.; Sept. 5, 2024 – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and X-Chem, leader...
Cancer Research Horizons appoints Therapeutic Innovation board to drive drug discovery strategy
LONDON, UK, 22 August 2024 – Cancer Research Horizons, the innovation arm of Cancer Research UK, has appointed Carlos Garcia-Echeverria,...
X‑Chem Strengthens Its Data-Driven Discovery Services With New CBO Appointment
WALTHAM, Mass.; June 20, 2024 (Business Wire) – Small molecule drug discovery acceleration experts and DNA-encoded library (DEL) technology pioneers...
X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy
WALTHAM, Mass.; April 2, 2024 (Business Wire) – X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today...
Fibrolamellar Cancer Foundation: New research collaboration with X‑Chem
FCF is pleased to announce the establishment of a research collaboration with X-Chem, a global leader in DNA-encoded library (DEL) technology. Through...
X‑Chem Transitions Executives into New Roles, Appoints New Chief Executive Officer
WALTHAM, Mass.; Jan. 4, 2024 (Business Wire) – X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today...